Forebrain overexpression of CaMKII abolishes cingulate long term depression and reduces mechanical allodynia and

Feng Wei1, Guo-Du Wang, Chao Zhang

  • 1Department of Physiology, Faculty of Medicine, University of Toronto, 1 King's College Circle, University of Toronto, Toronto, M5S 1A8, Canada. fwei001@umaryland.edu

Molecular Pain
|June 17, 2006
PubMed

Insights

Overexpressing Ca2+/calmodulin-dependent kinase II (CaMKII) in the mouse forebrain reduced pain sensitization without affecting acute pain responses. This suggests CaMKII

Area of Science:

  • Neuroscience
  • Molecular Biology

Background:

  • Synaptic plasticity is crucial for learning, memory, pain, and addiction.
  • Glutamate NMDA receptor activation and protein kinases, like Ca2+/calmodulin-dependent kinase II (CaMKII), modulate synaptic efficacy.
  • CaMKII's role in synaptic plasticity and memory is established, but its effect on forebrain pain responses is unclear.

Purpose of the Study:

  • To investigate the role of Ca2+/calmodulin-dependent kinase II (CaMKII) in forebrain areas on behavioral responses to tissue injury.
  • To determine if increased CaMKII activity influences pain sensitization and related behaviors.

Main Methods:

  • Utilized genetic and pharmacological techniques for temporal and spatial restriction of CaMKII overexpression in mouse forebrain.
  • Assessed behavioral responses to tissue injury, including allodynia and hyperalgesia.
  • Examined synaptic depression in the anterior cingulate cortex (ACC) following prolonged stimulation.

Main Results:

  • Genetic overexpression of CaMKII in the mouse forebrain selectively inhibited tissue injury-induced behavioral sensitization (allodynia and hyperalgesia).
  • Behavioral responses to acute noxious stimuli remained unaffected by CaMKII overexpression.
  • CaMKII overexpression inhibited synaptic depression in the ACC, indicating a role in regulating cingulate neurons.

Conclusions:

  • Neuronal CaMKII activity in the forebrain plays a significant role in the development and maintenance of persistent pain.
  • Targeting CaMKII in the forebrain may offer a therapeutic strategy for managing persistent pain conditions.

Related Concept Videos